Your browser doesn't support javascript.
loading
Hypertrophic effect of inhaled beta2 -agonist with and without concurrent exercise training: A randomized controlled trial.
Jessen, S; Onslev, J; Lemminger, A; Backer, V; Bangsbo, J; Hostrup, M.
Afiliação
  • Jessen S; Section of Integrative Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
  • Onslev J; Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark.
  • Lemminger A; Section of Integrative Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
  • Backer V; Section of Integrative Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
  • Bangsbo J; Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark.
  • Hostrup M; Section of Integrative Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Scand J Med Sci Sports ; 28(10): 2114-2122, 2018 Oct.
Article em En | MEDLINE | ID: mdl-29777633
Due to a high prevalence of asthma and exercise-induced bronchoconstriction in elite athletes, there is a high use of beta2 -adrenoceptor agonists (beta2 -agonists) in the athletic population. While anabolic in rodents, no study has been able to detect hypertrophy in humans after chronic beta2 -agonist inhalation. We investigated whether inhaled beta2 -agonist, terbutaline, alters body composition and metabolic rate with and without concurrent exercise training in healthy young men. Sixty-seven participants completed a 4-week intervention of daily terbutaline (8 × 0.5 mg) or placebo treatment without concurrent training (habitual; n = 23), with resistance (n = 23) or endurance (n = 21) training 3 times weekly. Before and after the interventions, participant's body composition was determined by dual-energy X-ray absorptiometry and resting metabolic rate and substrate oxidation by indirect calorimetry. Terbutaline increased lean body mass by 1.03 kg (95% CI 0.29-1.76; P < .05) and 1.04 kg (95% CI 0.16-1.93; P < .05) compared to placebo in the habitual and resistance training group, respectively, but had no effect compared to placebo in the endurance training group [-0.56 kg (95% CI -1.74-0.62; P > .05)]. Fat mass, bone mineral content, and resting metabolic rate did not change differently between treatments with the intervention. Daily inhalation of terbutaline in near-therapeutic doses induces skeletal muscle growth. This observation should be a concern for antidoping authorities.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terbutalina / Composição Corporal / Exercício Físico / Músculo Esquelético / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terbutalina / Composição Corporal / Exercício Físico / Músculo Esquelético / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article